A halotolerant Staphylococcus gallinarum strain isolated from brine lemon pickle grew at 20% NaCl and removed 45% of water ...

How to diagnose 'persistent infection' that leads to gastritis, gastric ulcers, and gastric cancer —Helicobacter pylori ...

Oct 2 (Reuters) - An advisory panel to the US Food and Drug Administration handed Grail's (GRAL.O), opens new tab Galleri blood test a milestone win last week, saying the early cancer detection test's ...

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA's Molecular and Clinical Genetics ...

A divided Food and Drug Administration panel narrowly backed a controversial blood-based cancer test Wednesday, a step forward for an emerging field of cancer screenings that could offer less invasive ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Multi-Cancer Early Detection (MCED) testing is a rapidly growing field. The Galleri blood ...

A U.S. Food and Drug Administration advisory panel voted in favor of recommending that the agency approve a blood test for multiple cancers on Wednesday. The assay, called the Galleri test, is ...

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers early. By Nina Agrawal An advisory committee to the Food and Drug ...

Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it’s far from clear how well it works. Grail Inc.’s ...

Matthew Herper covers medical innovation — both its promise and its perils. A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. This undated photo provided by Grail Inc. on ...

A key advisory committee that reviews medical devices for the Food and Drug Administration recommended the agency approve the first multi-cancer blood test for people 50 and over. Grail, the company ...